---
document_datetime: 2025-05-02 19:51:31
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/neorecormon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: neorecormon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.4457517
conversion_datetime: 2025-12-29 23:15:12.299457
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## NeoRecormon

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, please also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | C.I HUMAN AND VETERINARY MEDICINAL | 01/05/2025                          |                                             | SmPC,                            |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000262770   | PRODUCTS - C.I.z Change(s) in the SmPC, labelling or package leaflet of human medicinal products in order to adapt to a recommendation of a competent authority , e.g. a Core SmPC, following the assessment of an Urgent Safety Restriction etc. Implementation of wording agreed by the competent authority that require additional minor assessment, e.g. translations are not yet agreed upon. - Accepted C.I.z (Type IB) - to update the section 4.4 of the SmPC and section 2 of the Package Leaflet as per EMA's new polysorbate excipient labelling requirement. In addition, QRD version 10.4 update was applied in section 6 of the Package Leaflet where the contact details of the following countries were also updated: Luxembourg, Malta, Bulgaria, Cyprus, Greece. UK (NI) was removed accordingly. Labelling was updated with minor editorial corrections. Furthermore, MAH applied some editorial corrections in the following languages: IT, MT, DA, NL, LV, BG, HR, CS, ET, DE, HU and SL. Finally, the MAH has also taken the opportunity to replace the word EXP for expiry date and Lot for batch number instead of local language variants in Annex IIIA and Annex IIIB, in line with the global standardized preprints initiative in all the   | Labelling and PL   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|

<div style=\"page-break-after: always\"></div>

| and Poland).   |
|----------------|